AbbVie - Short Term - We look to Buy at 119.00 (stop at 114.50) Previous resistance level of 119.95 broken. A move higher has resulted in prices breaking from the previous range and confirmed our bullish expectation. We have a Gap open at 118.86 from 03/12/2021 to 06/12/2021. Further upside is expected although we prefer to set longs at our bespoke support...
DISCLAIMER -> This is not a financial advice. This is just an opinion.
DISCLAIMER -> This is not a financial advice. This is just an opinion.
Trendline Break At Resistance Zone Short Entry 108.4 Stop 113 Target 85 Risk management is much more important than a good entry point. The max Risk of each plan should be less than 1% of an account. I am not a PRO trader. I trade option to test my trading plan with small cost.
Almost exactly one year ago the 50 day crossed below the 200 day. Shortly after the price skyrocketed on earnings. Will history repeat itself or is it going to be a nursery rhyme that ends with our hero being devoured by a bear? Those that don’t know teach, and those that don’t know technical analysis use the esoteric approach.
Welcome to our Weekly V2-Trade Setup ( ABBV ) ! - 4 HOUR Slowly rising market structure. DAILY Expecting a pushback to previous wave highs at least.. WEEKLY Great long entries! - STOCK SETUP BUY ABBV ENTRY LEVEL @ 111.19 SL @ 107.66 TP @ Open Max Risk: 0.5% - 1%! (Remember to add a few pips to all levels - different Brokers!) Leave us a comment or like to...
ABBV: AbbVie 2021-09-28 18:00:00 FDA Approves QULIPTA™ (atogepant), the First and Only Oral CGRP Receptor Antagonist Specifically Developed for the Preventive Treatment of Migraine
Prices formed a falling wedge and breached its upper boundary at 107 to target 110.90 Stop losses closing below 106.38
Following 7% drop after FDA calls for arthritis drug to be labelled with heart-risk warning
Hopefully we see a nice reversal based on the news this morning 9/10/2021.
False selling better to catch the falling knife from his handle I can anticipate this is the right handle to take it. Happy trading.
ABBV got obliterated on some news, it broke down beneath its support level of 111 all the way down to 106, but got bought back up and closed above 111 holding the support level. This is looking like more boucne will happen tomorrow, with a long wicked candle showing false breakdown
I still think Abbvie is undervalued great dividend growth play Added more today on the dip the 200ma Daily looks like strong support
Bad news event )o: Price broke handle low of the large cup and handle pattern I drew a while back but never posted. The handle low was 110. "FDA requires updated warnings on JAK inhibitors citing increased risks of heart events." ABBV is involved in the marketing of a JAK inhibitor which is for arthritis. Good dividend payer with a yield at 4.31%. PE 9.5 ...
$ABBV - Watch for calls above 120 & Puts below trend line, seeing some RSI divergence
The PEAD projected a Bullish outlook for $ABBV after a Positive over reaction following its earnings release placing the stock in drift B with an expected accuracy of 33%. If you would like to see the Drift for another stock please message us. Also click on the Like Button if this was useful and follow us or join us.
Love this company Q2 great numbers, the management team is strong adding some shares here.